Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

How to Improve the Definition of Chronic Lymphocytic Leukemia Outcome Using a Simple Flow Cytometric Score Based on CD49d and Homing Marker Expression

Valentina Giudice, MD, Monia Rocco, PhD, Luca Pezzullo, MD, Giancarlo Villani, Rosa Rosamilio, MD, Luigi Marino, Silvana Annunziata, MD, Raffaele Fontana, MD, Idalucia Ferrara, MD, Bianca Serio, MD, Carmine Selleri, MD

Blood (2016) 128 (22): 5567.

https://doi.org/10.1182/blood.V128.22.5567.5567

Published: 2016

Journal Articles

The Role of B Regulatory Cells in the Immunological Escape of Tumor Cells in Hodgkin Lymphoma

Valentina Giudice, MD, Monia Rocco, PhD, Giancarlo Villani, Rosa Rosamilio, MD, Luca Pezzullo, MD, Bianca Serio, MD, Idalucia Ferrara, MD, Carmine Selleri, MD

Blood (2016) 128 (22): 1768.

https://doi.org/10.1182/blood.V128.22.1768.1768

Published: 2016

Journal Articles

Cytomegalovirus Reactivation Prophylaxis With Low Dose Valgancyclovir After Hematopoietic Stem Cell Transplantation

Bianca Serio, MD, Luca Pezzullo, MD, Raffaele Fontana, MD, Silvana Annunziata, MD, Rosa Rosamilio, Idalucia Ferrara, MD, Monia Rocco, Valentina Giudice, Mariarosaria Sessa, Ciro De Luca, Carmine Selleri, MD

Blood (2013) 122 (21): 4578.

https://doi.org/10.1182/blood.V122.21.4578.4578

Published: 2013

Journal Articles

Induction Therapy With Continuous Alternate-Day Low Dose Lenalidomide Combined With Low-Dose Prednisone In Octogenarian Multiple Myeloma Patients

Luca Pezzullo, MD, Bianca Serio, MD, Raffaele Fontana, MD,, Idalucia Ferrara, MD, Mariarosaria Sessa, Valentina Giudice, Giancarlo Villani, Monia Rocco, Carmine Selleri, MD

Blood (2013) 122 (21): 5394.

https://doi.org/10.1182/blood.V122.21.5394.5394

Published: 2013

Journal Articles

Efficacy of Nilotinib in EARLY Chronic PHASE CML Patients WHO Have Suboptimal Cytogenetic or Molecular Response to Imatinib. A Multicentric Retrospective Study

Luigia Luciano, MD, Elisa Seneca, MD, Mario Annunziata, MD, Luca Pezzullo, MD, Paolo Danise, MD, Ursula Sessa, MD, Fausto Palmieri, MD, Mariolina Iovine, MD, Roberto Vallone, MD, Fabrizio Pane

Blood (2012) 120 (21): 4454.

https://doi.org/10.1182/blood.V120.21.4454.4454

Published: 2012

Journal Articles

Front-Line Therapy of Acute Myeloid Leukemia in Elderly Patients. Safety and Efficacy of Two Different Schedules of Fludarabine-Based Regimens.

Stefano Rocco, MD, Giancarla Pricolo, Luca Pezzullo, MD, Antonella Prudenzano, Olimpia Finizio, MD, Francesco Casulli, MD, Lucia Bene, MD, Carlo De Rosa, MD, Vincenzo Mettivier, MD, Patrizio Mazza, MD

Blood (2005) 106 (11): 4637.

https://doi.org/10.1182/blood.V106.11.4637.4637

Published: 2005

Journal Articles

Acute Myeloid Leukemia in the Elderly, Intensive or Maintenance Therapy? Our Experience in Patients over 65 Years.

Vincenzo Mettivier, MD, Luca Pezzullo, MD, Stefano Rocco, MD, Olimpia Finizio, MD, Lucia Bene, MD, Carlo De Rosa, MD, Giuseppe Rodolfo Nunziata, MD, Marina Liberati, MD

Blood (2005) 106 (11): 4640.

https://doi.org/10.1182/blood.V106.11.4640.4640

Published: 2005

Journal Articles

Ca 15-3 a Marker for the Megaloblastic Anaemia?.

Vincenzo Mettivier, MD, Luca Pezzullo, MD, Olimpia Finizio, MD, Stefano Rocco, MD, Lucia Bene, MD, Carlo De Rosa, MD

Blood (2005) 106 (11): 3733.

https://doi.org/10.1182/blood.V106.11.3733.3733

Published: 2005

NARROW

How to Improve the Definition of Chronic Lymphocytic Leukemia Outcome Using a Simple Flow Cytometric Score Based on CD49d and Homing Marker Expression

The Role of B Regulatory Cells in the Immunological Escape of Tumor Cells in Hodgkin Lymphoma

Cytomegalovirus Reactivation Prophylaxis With Low Dose Valgancyclovir After Hematopoietic Stem Cell Transplantation

Induction Therapy With Continuous Alternate-Day Low Dose Lenalidomide Combined With Low-Dose Prednisone In Octogenarian Multiple Myeloma Patients

Efficacy of Nilotinib in EARLY Chronic PHASE CML Patients WHO Have Suboptimal Cytogenetic or Molecular Response to Imatinib. A Multicentric Retrospective Study

Front-Line Therapy of Acute Myeloid Leukemia in Elderly Patients. Safety and Efficacy of Two Different Schedules of Fludarabine-Based Regimens.

Acute Myeloid Leukemia in the Elderly, Intensive or Maintenance Therapy? Our Experience in Patients over 65 Years.

Ca 15-3 a Marker for the Megaloblastic Anaemia?.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only